Breast cancer brain transfer

Breast cancer brain transfer means that breast cancer cells spread to the brain, including through blood circulation, and develop tumours in the brain. First, clinically expressed headaches are one of the most common symptoms, usually continuing or intermittent, to varying degrees. This may be due to tumors that oppress the surrounding brain tissues, cause internal pressure to increase or irritate the brain. As the disease progresses, headaches may gradually increase and medications are ineffective. Vomiting often occurs at the same time as headaches, mostly in the form of jet vomiting. This is due to an increase in internal pressure to stimulate vomiting. In general, vomiting is not accompanied by gastrointestinal symptoms such as nausea and has little to do with diet. Visual impairment can be manifested in loss of vision, loss of vision, re-vision, etc. The tumour oppresses the optic nerve, the intersection of the vision can cause visual impairment. Patients may have blurred visions, blurred visions of one side of the object, or re-emergence. Physical incapacitation may result from physical incapacitability or from a tumour of the cerebral palsy which impairs the motor-conductive circuit or directly infringes the motor-cortical zone. Serious can lead to paraplegicness, i.e. complete loss of motor function on one side. Patients may suffer from such symptoms as unstable walking, unstable carrying, numbness on one side. Cognitive and mental disorders manifest themselves in memory loss, lack of focus, mental retardation, emotional change, etc. Tumours affect the cognitive function of the brain or cause brain oedema, among others, which can cause these symptoms. Patients may experience personality changes, behaviour anomalies, agitation or depression. Some of the patients with epilepsy can have epilepsy, and may have whole-body or limited onset. The tumor stimulates an abnormal discharge of brain neurons that causes epilepsy. Epilepsy can be the first symptoms of the patient and may occur as the disease progresses. II. Diagnosing method: MRI: The preferred method for diagnosing breast cancer brain transfer. MRI has a high soft tissue resolution that clearly shows the anatomy structure and pathologies of the brain. MRI can also better detect a tiny brain transfer stove. Performance: On the T1 weighted image, brain transfer stoves usually show low or some kind of signal; on the T2 weighted image, high signal. With enhanced scanning, transfer stoves can be significantly enhanced. Computer fault scan (CT): CT tests can also be used to diagnose brain transfer, but the detection rate for micro-cookers is lower than MRI. CT can show the approximate structure of the brain and larger transfer stoves. Performance: Brain transfer stoves are usually low-density or equal-density images on CT images and can be enhanced by enhanced scanning. Brain vertebrate fluid is obtained from vertebrate punctures, cytological, biochemical and tumor markers. If cancer cells are found in brain spinal fluid, they can be clearly diagnosed as brain transfer. Brain vertebral fluids can also help to determine whether there is a brain transfer and to assess the effects of treatment. An electronic launch tort scanned (PET) PET examination allows full body imaging and helps to detect transfer stoves outside the brain. For diagnosis of brain transfer of breast cancer, PET can provide more information, but not as a routine method of detection. In PET images, brain transfer stoves are usually highly metabolic. III. Certificates for the treatment of treatments: Surgery can be considered for single-haired brain transfer stoves, patients who are in surgeryable areas and who are generally in better condition. The operation can reduce the increase in intracranial pressure, reduce the tumour pressure on the surrounding brain tissue and improve the quality of life of patients. Risks and complications: Surgery risks include haemorrhage, infection, neurological impairment, etc. Complications such as cerebral oedema and epilepsy may occur after surgery. Radiotherapy for whole brain: one of the main treatments for breast cancer brain transfer. Full brain treatment can mitigate symptoms and extend life, but may have some side effects, such as loss of hair, fatigue, memory loss, etc. Stereo-directed radiotherapy (RSS): SRS can be an effective treatment for single-headed or a few brain transfer patients. SRS has the advantage of being precise in location, concentration of doses and small damage to the surrounding normal tissue. Risks and complications: Radiation treatment can cause complications such as cerebral oedema, radioactive brain failure, cognitive dysfunction, etc. Chemical Treatment Adaptation Certificate: The efficacy of chemotherapy is relatively poor for breast cancer brain transfer patients. However, chemotherapy can be used as an assistive treatment for subtypes of breast cancer that are sensitive to chemotherapy, such as triple-negative breast cancer. Drug selection: Due to the existence of a blood and brain barrier, many chemotherapy drugs are difficult to enter and function in the brain. Some of the drugs that can be used through the blood and brain barrier, such as Carmostin and Methamine, can be used for breast cancer brain transfer treatment. Targeting treatment is for HeR2 positive breast cancer: for HeR2 positive breast cancer brain transfer patients, drugs such as tutto-jole, Patto-jole, Lapatini, etc. can be used in conjunction with treatment or chemotherapy to improve the effectiveness of treatment. For other targets: For breast cancer patients with a specific gene mutation or target, the appropriate target can be selected for treatment with a drug. For example, the use of PARP inhibitors could be considered for patients with genetic mutations at BRCA. The treatment supports the control of intracircle pressure: the use of dehydration drugs such as glycerol, glycerine nuts, and sugary hormonals such as disemisons can reduce brain oedema and lower intracircle pressure. Anti-eclampsia treatment: For patients with epilepsy, anti-eclampsia medication is required. Nutritional support: Provide adequate nutritional support to patients, maintain hydrolytic balance and increase their immunity.